--- slug: patient-capital type: concept summary: "Capital deployed with a multi-year horizon and concessionary or risk-tolerant terms because the outcome needs time and flexibility commercial capital will not provide." created: 2026-05-06 updated: 2026-05-23 related: impact-first-investing: relation: depends-on note: "Patient capital only makes sense once the office has declared that a specific line item sits on the impact-first side of the underwriting axis." catalytic-firstloss-capital: relation: enables note: "A first-loss tranche usually needs patient capital because the provider is accepting time, loss severity, or concession that senior capital will not carry." blended-finance-stack: relation: enables note: "A blended finance stack often depends on patient capital to hold the early, subordinated, or concessionary layer that makes senior capital willing to enter." program-related-investment: relation: supports note: "A PRI is one common legal form through which a private foundation can express patient capital under a primary charitable purpose." daf-patient-capital: relation: used-by note: "A donor-advised fund becomes a patient-capital vehicle only when the sponsor permits multi-year recoverable or investment holdings under a governed deployment plan." change-theory: relation: scoped-by note: "The theory of change explains why patience and concession are necessary for the outcome, rather than decorative terms added after approval." additionality: relation: tested-by note: "Additionality tests whether the patience or concession changed what happened, or merely sat beside an outcome that would have occurred anyway." --- # Patient Capital > **Concept** > > Vocabulary that names a phenomenon. *Capital intentionally deployed with a multi-year horizon and concessionary or risk-tolerant terms because the intended outcome needs time, risk absorption, or flexibility that conventional commercial capital will not provide.* *Also known as: long-horizon catalytic capital, concessionary capital, flexible impact-first capital.* ## What It Is Some capital pools can wait. Fewer are authorized to accept that waiting earns less money, loses more principal, or requires a structure a commercial lender would reject. **Patient capital** names that second posture. Inside a family office, patient capital means capital intentionally deployed with a long horizon and a documented tolerance for concession, loss, illiquidity, or flexible repayment because the intended outcome needs those terms. The term belongs on the impact-first side of [Impact-First vs. Finance-First](impact-first-investing.md). Finance-first capital can be long-term; a family can hold timberland, private-company shares, or a public-equities portfolio for decades and still require market-rate return. Patient capital is narrower. The office records why a desired outcome needs terms the market is not already providing. Family capital is unusually well suited to this posture because it is not always bound by a fund life. A founder-controlled balance sheet, private foundation, donor-advised fund (DAF), purpose trust, or family investment LLC may be able to hold an asset longer than a ten-year private-equity fund. But long tenor alone is not enough. Cash sitting in a DAF for eight years is dormant charitable capital. A twelve-year growth-equity hold with market-rate targets is long-term capital. Patient capital carries a named concession or risk tolerance for a stated impact purpose. ## Why It Matters The field uses *patient capital* too loosely. A pitch deck calls a ten-year fund patient because the hold period is longer than public-market trading. A DAF sponsor calls an inactive account patient because the assets have not yet been granted out. A principal calls a below-market loan patient without stating the concession in basis points, the loss budget, or the impact reason the concession exists. Loose usage produces operating failures. The investment committee cannot price the concession. The impact team cannot test whether the capital changed anything. The family council cannot tell disciplined patience from an excuse for assets to sit idle. The term has to carry a burden. It tells the office what it is giving up, for how long, and why. Without that precision, patient capital becomes a virtue word. With it, the office can govern a concession the same way it governs any other allocation term. ## How to Recognize It A line item is patient capital only when four facts are documented before approval: 1. **Tenor.** The expected holding period, review window, or maturity date. Seven years or longer is common for market-building work, but the number matters less than the documented reason. 2. **Concession or risk tolerance.** The exact way the capital departs from commercial terms: lower coupon, longer grace period, subordinated position, capped return, first-loss budget, higher probability of principal loss, or unusually flexible repayment. 3. **Impact predicate.** The [Theory of Change](change-theory.md) that explains why patience or concession is necessary for the outcome. 4. **Recycling or exit rule.** What happens if the capital returns, partially returns, or fails to return. Those four facts distinguish patient capital from adjacent terms: | Nearby term | Why it is not enough | Patient-capital test | |---|---|---| | Long-term holding | The office can hold for decades while requiring market-rate return. | What financial term changed because the impact case required it? | | Dormant philanthropy | Assets can sit in a DAF or foundation account without serving anyone. | Which investee or intermediary received time, risk tolerance, or flexible capital? | | Impact-aligned investing | A portfolio can screen for impact while keeping a conventional return floor. | What concession, loss budget, or flexibility was authorized in advance? | | Catalytic capital | Catalytic capital may be patient, risk-tolerant, flexible, concessionary, or some combination. | Which form of patience is doing work in this structure? | The test is practical: if the office cannot point to tenor, concession, impact predicate, and exit or recycling rule, it may be describing aspiration. It is not yet governing patient capital. ## How It Plays Out Consider a $1.1B single-family office with a $140M private foundation, an $85M DAF, and a taxable investment LLC. The family wants to finance home-repair and heat-pump retrofits for low-income households in three cold-weather counties where utility bills drive housing insecurity. Banks will lend against the collateral only after the contractor network is trained, default data exists, and repayment behavior is visible. Local nonprofits can originate demand but cannot carry the credit risk. A grant-only program would help several hundred households and then end. The family council reviews a proposed $50M patient-capital sleeve with a twelve-year review window. The question is not whether the family is "being patient." The question is whether each dollar has a job that requires time, concession, or risk tolerance. | Layer | Vehicle | Terms | Patient-capital job | |---|---|---|---| | $6M | Foundation grants | Two-year contractor training, intake, and measurement support. | Build the market infrastructure the loans need. | | $14M | DAF recoverable-grant pool | Zero-interest recoverables to nonprofit originators, seven-year recovery target, 40% write-off budget. | Let nonprofit lenders prove repayment behavior without losing program control. | | $12M | Foundation PRI | Ten-year 1.5% subordinated note to the CDFI intermediary. | Hold first-loss risk below senior lenders while serving a charitable purpose. | | $18M | Taxable family LLC | Twelve-year preferred-equity commitment capped at 4% internal rate of return. | Provide first-close capital that gives the intermediary enough committed capital to raise senior debt. | The office does not call the whole $50M "impact investing" and move on. It reads each layer against the four-fact test. The DAF recoverable-grant pool carries a seven-year target and a 40% write-off budget. The PRI carries a ten-year maturity and a coupon far below the senior lenders' rate. The taxable LLC commitment caps return, accepts illiquidity, and sits in the first close so the intermediary can show committed risk capital to banks. The theory of change is narrow: flexible early capital should produce enough originated loan volume, contractor capacity, repayment data, and household energy-savings evidence to bring senior lenders into the structure by year four. The [Additionality](additionality.md) test is equally narrow. If the same lending volume and senior participation would have happened on the same timeline without the family sleeve, the patience did not do catalytic work. By year five, the program has financed 1,900 households, trained forty-two contractors, and brought two regional banks into a $70M senior facility. The foundation writes off $4.8M of the DAF recoverables, within the approved loss budget. The PRI is performing. The taxable LLC preferred-equity line is marked below what a market-rate private-credit allocation would have earned. The committee can point to the concession: roughly 300 to 450 basis points per year against the office's private-credit benchmark, accepted for a defined market-building purpose. That is patient capital. If the same family had left $50M in DAF cash for five years while calling itself patient, nothing would have been financed, no senior lender would have changed behavior, and no concession would have been governed. The label would have hidden inaction. ## Caveats and Open Questions Patience is not automatically good underwriting. A long horizon can hide a weak credit file. A concession can become a subsidy without a boundary. A family principal may be willing to wait, but the successor council, foundation board, or trustee still needs written authority when the founder is no longer the voting authority. Recycling also changes the interpretation. Some patient capital is designed to return and redeploy. Some is expected to absorb loss. Some sits between those poles, with partial recovery treated as evidence that the market can support senior capital later. The documents should say which logic applies. The fiduciary question depends on the vehicle. A private foundation PRI, a DAF recoverable grant, a trust-held impact investment, and a taxable family LLC commitment do not answer to the same legal, tax, and governance tests. The family may use the same patient-capital vocabulary across them, but counsel and the committee have to evaluate each vehicle on its own terms. ## Consequences The first benefit is precision. Once patient capital is defined by tenor, concession, impact predicate, and recycling rule, everyone knows what is being governed. The investment committee can price the concession. The program team can test whether the outcome needed it. The foundation board can decide whether a PRI is the right vehicle. The DAF sponsor can be evaluated for whether it permits the intended recoverable or investment form. The family council can revisit the sleeve later without guessing what the founder meant. The second benefit is composition. Patient capital is the ingredient that lets [Catalytic First-Loss Capital](catalytic-firstloss-capital.md), [Blended Finance Stack](blended-finance-stack.md), recoverable grants, PRIs, and DAF-based impact-first strategies fit together. The office can decide which pool of capital should carry which kind of patience, instead of forcing every impact idea into either a grant bucket or a market-rate investment bucket. The liabilities are equally real. Patient capital is slow, staff-intensive, and hard to benchmark. It can hide weak underwriting if the office treats concession as permission to stop asking financial questions. It can create dependency if the concession is renewed automatically. It can also become a reputational claim larger than the evidence supports; a family that absorbs a loss has not necessarily changed an outcome. The discipline is to treat patience as a term-sheet item, not a virtue word. Patient capital does not let the office waive underwriting, and it cannot make a weak investment strong by renaming the weakness. It changes what underwriting has to prove. ## Sources - Acumen, [*Investing as a Means: 20 Years of Patient Capital*](https://acumen.org/reports/investing-as-a-means-report/), 2021. The clearest practitioner account of patient capital as long-term, risk-tolerant investment used to build markets that conventional capital will not yet finance. - Catalytic Capital Consortium, [*Catalytic Capital Definition*](https://www.macfound.org/programs/catalytic-capital-consortium/). The field's canonical definition of catalytic capital as "patient, risk-tolerant, concessionary, and flexible," produced by the MacArthur, Rockefeller, and Omidyar consortium. - Social Finance, [*The Untapped Potential of Impact-First Investing*](https://socialfinance.org/insight/the-untapped-potential-of-impact-first-investing/), 2023. The Rockefeller Foundation-backed DAF analysis that frames donor-advised funds as an under-used pool for impact-first, concessionary deployment. - Antony Bugg-Levine and Jed Emerson, *Impact Investing: Transforming How We Make Money While Making a Difference*, Jossey-Bass, 2011. The foundational book treatment of impact investing's return-continuum logic and the early field vocabulary around capital that intentionally accepts tradeoffs for social purpose. --- *This entry describes a structural pattern and is not legal, tax, or investment advice. Consult qualified counsel and tax advisors licensed in your jurisdiction before adopting any structure described here.* --- - [Next: Governance and Continuity](governance.md) - [Previous: The Great Wealth Transfer](great-wealth-transfer.md)